The Center for Drug Evaluation and Research is confirmed to be a part of the FDA agency.
2 reports, 2 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Center for Drug Evaluation and Research is confirmed to be a part of the FDA agency.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Center for Drug Evaluation and Research
FDA research center
Nothing else this week.
Related events
- Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.
- The FDA appointed Patrizia Cavazzoni to the permanent director role of the Center for Biologics Evaluation and Research (CBER).
- FDA approval enables commercial opportunity involving CBRE Group.
- The FDA is reviewing drug data and company resubmissions, while also overseeing the functions of the U.S. Department of Health and Human Services.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.